Co-Diagnostics: Richard Abbott, David Nielsen, Christopher Thurston, Seth Egan

Co-Diagnostics has appointed Richard Abbott as president, David Nielsen as chief operations officer, Christopher Thurston as chief technology officer, and Seth Egan as chief commercialization officer.

Abbott previously served as president of Advanced Conceptions, a wholly owned subsidiary of Co-Dx, and as VP of engineering at BioFire Diagnostics. Nielsen was previously the COO of Idaho Molecular, a company also acquired by Co-Dx, and served in R&D leadership roles at BioFire and BioFire Defense. Thurston has experience as a software designer and architect for BioFire Defense and BioMérieux. Egan has been with Co-Dx since it was founded, leading its sales and marketing efforts and overseeing the firm's joint venture in India.